Episode Details

Health Affairs' Leslie Erdelack and Jessica Bylander discuss the large amount of news and controversy over the abortion pill mifepristone as the drug's 2000 approval -- and subsequent changes to how patients can access it -- make their way through the courts.

NOTE: This episode was recorded in the afternoon of April 13, 2023, shortly before the Justice Department requested the Supreme Court to restore access to the mifepristone.

Related Links:

• FDA's Liberalization of Mifepristone Dispensing: Securing The Future Of Access To Medical Abortion (Health Affairs Forefront)
• Drugmakers sign letter supporting FDA and calling for reversal of Texas judge's mifepristone ruling (CNN)
• Abortion Medication Mifepristone Will Remain Legal for Now, but With More Restrictions (Vanity Fair)
• United States Department of Justice Statement - April 13, 2023

Currently, more than 70 percent of our content is freely available — and we’d like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.